Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- SPOTLIGHT203Independent statistical analysis of BO-112 With Pembrolizumab in Unresectable Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04570332).
- SPPIndependent statistical analysis of Supporting Parents Program: Intervention for Families in CPS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01332851).
- SPP2Independent statistical analysis of Effect of Behavioral Nudges on Serious Illness Conversation Documentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04867850).
- SPREADIndependent statistical analysis of Sleep to Prevent Evolving Affecting Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02988375).
- SPREAD-NETIndependent statistical analysis of SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02325531).
- Sprifermin (AS902330) in Cartilage Injury Repair (CIR): Complete Statistical AnalysisIndependent statistical analysis of Sprifermin (AS902330) in Cartilage Injury Repair (CIR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01066871).
- SPRINGIndependent statistical analysis of High-Risk Neuroblastoma Chemotherapy Without G-CSF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02786719).
- SPRING-2Independent statistical analysis of A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPTIndependent statistical analysis of Brain Biomarkers of Response to Treatment for Apraxia of Speech: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02046941).
- SPT for Sensitization of Collagen Dressing: Complete Statistical AnalysisIndependent statistical analysis of SPT for Sensitization of Collagen Dressing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06271993).
- SQ53 Disinfectant Wipes for Prevention of CRBSI: Complete Statistical AnalysisIndependent statistical analysis of SQ53 Disinfectant Wipes for Prevention of CRBSI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04822467).
- SR-WBV Training for Frail Elderly in the Skilling up Stage: Complete Statistical AnalysisIndependent statistical analysis of SR-WBV Training for Frail Elderly in the Skilling up Stage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01704976).
- SRSIndependent statistical analysis of Stereotactic Radiosurgery (SRS) Dose-Escalation Study for Brain Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02645487).
- SRSEIndependent statistical analysis of Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01362790).
- SSVSIndependent statistical analysis of Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SSWIndependent statistical analysis of Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers Phase I: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients: Complete Statistical AnalysisIndependent statistical analysis of STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- STABIL-BIndependent statistical analysis of Sequential Therapy for the Treatment of Severe Bipolar Depression.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02974010).
- Stability of the Medial Pivot Total Knee Prosthesis: Complete Statistical AnalysisIndependent statistical analysis of Stability of the Medial Pivot Total Knee Prosthesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02577978).
- Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Staccato Loxapine in Agitated Patients With Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Staccato Loxapine in Agitated Patients With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721955).
- Staccato Prochlorperazine in Migraine (Out Patient): Complete Statistical AnalysisIndependent statistical analysis of Staccato Prochlorperazine in Migraine (Out Patient): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00422812).
- STAGEIndependent statistical analysis of A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- STAGEIndependent statistical analysis of STorz Against Glidescope Effectiveness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01632683).
- Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab: Complete Statistical AnalysisIndependent statistical analysis of Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab: primary endpoint results, effect estimate with confidence…
- Staged DEEPIndependent statistical analysis of Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01661205).
- STAGED-PKD-EXTIndependent statistical analysis of Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- STAMPVAIndependent statistical analysis of Sharing and Talking About my Preferences: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03103828).
- STANDIndependent statistical analysis of Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- STANDIndependent statistical analysis of Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Stand if You Can: A Standing Intervention in Long Term Care: Complete Statistical AnalysisIndependent statistical analysis of Stand if You Can: A Standing Intervention in Long Term Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Standard Colonoscopy Versus Colonoscopy With Endocuff Vision: Complete Statistical AnalysisIndependent statistical analysis of Standard Colonoscopy Versus Colonoscopy With Endocuff Vision: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03361917).
- Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM): Complete Statistical AnalysisIndependent statistical analysis of Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004: Complete Statistical AnalysisIndependent statistical analysis of Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004: primary endpoint results, effect estimate with confidence…
- Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572): Complete Statistical AnalysisIndependent statistical analysis of Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Standardization of Surgery on the Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Standardization of Surgery on the Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00679913).
- STANDUP AHFIndependent statistical analysis of Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- STARIndependent statistical analysis of Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- STARIndependent statistical analysis of Safety Study of Abatacept to Treat Refractory Sarcoidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00739960).
- STARIndependent statistical analysis of Start Treatment and Recovery for Opioid Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04505540).
- STARIndependent statistical analysis of Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- STAR Cape+BKM120 MBC With Brain Met: Complete Statistical AnalysisIndependent statistical analysis of STAR Cape+BKM120 MBC With Brain Met: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02000882).
- STAR-OMIndependent statistical analysis of Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- STAR-VTIndependent statistical analysis of Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- STARDUSTIndependent statistical analysis of Liraglutide and Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04881110).
- STARR-NCIndependent statistical analysis of Supporting Tailored And Responsive PrEP in Rural North Carolina: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05984030).
- STARSIndependent statistical analysis of A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- STARSIndependent statistical analysis of Sun Protection and Tanning Awareness in Rural Schools: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06694571).
- STARTIndependent statistical analysis of Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02097641).